Log in

NYSE:SNYSanofi SEC Filings & 10K Form

$53.21
+0.76 (+1.45 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$52.70
Now: $53.21
$53.38
50-Day Range
$49.95
MA: $51.77
$53.77
52-Week Range
$37.62
Now: $53.21
$55.00
Volume1.18 million shs
Average Volume2.01 million shs
Market Capitalization$133.25 billion
P/E Ratio17.00
Dividend Yield2.23%
Beta0.67

SEC Filings

Sanofi (NYSE:SNY) SEC Filings

DateFilerForm TypeView
07/29/2020
10:16 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2020
9:13 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2020
5:06 AM
Inozyme Pharma, Inc. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
8:04 PM
Inozyme Pharma, Inc. (Issuer)
Sanofi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/07/2020
11:22 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2020
9:35 AM
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/26/2020
9:32 AM
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/24/2020
2:08 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2020
4:10 PM
REGENERON PHARMACEUTICALS, INC. (Subject)
Sanofi (Filed by)
Form SC 13D/A
06/17/2020
1:33 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2020
12:10 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/11/2020
5:45 PM
REGENERON PHARMACEUTICALS, INC. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
2:03 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2020
10:27 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/27/2020
10:38 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2020
12:29 PM
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/26/2020
11:42 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2020
5:11 AM
REGENERON PHARMACEUTICALS, INC. (Subject)
Sanofi (Filed by)
Form FWP
05/22/2020
5:25 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2020
12:47 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2020
5:15 AM
Sanofi (Filer)
Form S-8 POS
04/27/2020
3:39 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2020
11:37 AM
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
04/20/2020
8:40 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2020
9:12 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/07/2020
12:49 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2020
5:20 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/30/2020
9:29 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2020
8:14 AM
Sanofi (Filer)
Form 15-12B/A
03/16/2020
3:28 PM
Sanofi (Filer)
Form 15-12B
03/06/2020
12:02 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2020
3:07 PM
Sanofi (Filer)
Form IRANNOTICE
03/05/2020
1:55 PM
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/04/2020
2:54 PM
Sanofi (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
02/25/2020
7:00 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2020
7:08 AM
Sanofi (Filed by)
Unum Therapeutics Inc. (Subject)
Form SC 13G/A
02/10/2020
7:07 AM
Regulus Therapeutics Inc. (Subject)
Sanofi (Filed by)
Form SC 13G/A
02/10/2020
6:34 AM
BlackRock Inc. (Filed by)
Sanofi (Subject)
Form SC 13G/A
02/06/2020
1:20 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2020
8:45 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2020
2:38 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2020
6:04 AM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-T/A
01/21/2020
6:33 AM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-T/A
01/09/2020
4:23 PM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-T/A
01/07/2020
7:05 AM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-T/A
12/27/2019
4:27 PM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-T
12/11/2019
7:26 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2019
6:31 AM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-C
12/10/2019
10:13 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2019
6:50 AM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-C
12/09/2019
4:22 PM
Sanofi (Filed by)
Synthorx, Inc. (Subject)
Form SC TO-C
12/09/2019
4:19 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2019
12:14 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2019
5:48 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2019
12:43 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2019
4:00 PM
REGENERON PHARMACEUTICALS, INC. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
5:35 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2019
7:22 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
3:30 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
9:41 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
9:13 AM
Fulcrum Therapeutics, Inc. (Subject)
Sanofi (Filed by)
Form SC 13G
07/26/2019
5:16 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2019
10:39 AM
Fulcrum Therapeutics, Inc. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
6:30 PM
Fulcrum Therapeutics, Inc. (Issuer)
Sanofi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/16/2019
9:29 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2019
1:56 PM
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/28/2019
1:51 PM
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/18/2019
7:44 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2019
5:39 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/05/2019
8:14 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2019
5:10 AM
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/03/2019
3:02 PM
ALNYLAM PHARMACEUTICALS, INC. (Subject)
Sanofi (Filed by)
Form SC 13G/A
04/29/2019
9:57 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2019
9:15 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2019
7:19 PM
REGENERON PHARMACEUTICALS INC (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
1:35 PM
Sanofi (Filer)
Form IRANNOTICE
03/08/2019
1:30 PM
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/26/2019
6:41 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2019
5:12 AM
MyoKardia Inc (Subject)
Sanofi (Filed by)
Form SC 13G/A
02/15/2019
5:05 AM
MyoKardia Inc (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2019
12:14 PM
Sanofi (Filed by)
SCYNEXIS INC (Subject)
Form SC 13G/A
02/11/2019
10:06 AM
BlackRock Inc. (Filed by)
Sanofi (Subject)
Form SC 13G/A
02/11/2019
7:41 AM
Sanofi (Filed by)
Voyager Therapeutics, Inc. (Subject)
Form SC 13G/A
02/11/2019
7:37 AM
MyoKardia Inc (Subject)
Sanofi (Filed by)
Form SC 13G/A
02/11/2019
7:33 AM
Sanofi (Filed by)
Unum Therapeutics Inc. (Subject)
Form SC 13G
02/07/2019
1:52 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2019
7:53 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2019
2:13 PM
ALNYLAM PHARMACEUTICALS, INC. (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
8:07 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2018
10:27 AM
Sanofi (Filer)
Form CERT
12/31/2018
5:25 AM
Sanofi (Filer)
Form 8-A12B
12/31/2018
5:20 AM
Sanofi (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
12/18/2018
3:47 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2018
5:20 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2018
7:24 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2018
2:30 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2018
7:58 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2018
2:14 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/14/2018
8:33 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2018
4:01 PM
REGENERON PHARMACEUTICALS INC (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.